Rainer Kunstfeld Selected Research

Rainer Kunstfeld Research Topics

Disease

16	Neoplasms (Cancer) 01/2016 - 03/2003
10	Melanoma (Melanoma, Malignant) 01/2019 - 03/2003
6	Neoplasm Metastasis (Metastasis) 03/2015 - 04/2005
4	Basal Cell Carcinoma (Rodent Ulcer) 12/2018 - 06/2015
2	Inflammation (Inflammations) 02/2015 - 08/2004
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 02/2015 - 12/2003
2	Carcinogenesis 05/2014 - 04/2005
2	Psoriasis (Pustulosis Palmaris et Plantaris) 12/2006 - 08/2004
1	Granuloma Annulare 01/2018
1	Spasm (Spasms) 01/2017
1	Skin Neoplasms (Skin Cancer) 02/2015
1	Merkel Cell Carcinoma 01/2013
1	Contact Dermatitis (Eczema, Contact) 01/2011
1	Nevus (Nevi) 01/2011
1	Multiple Myeloma 05/2009
1	Skin Diseases (Skin Disease) 12/2006
1	Lymphatic Metastasis 04/2005
1	Hyperplasia 08/2004
1	Hypersensitivity (Allergy) 08/2004
1	Rheumatoid Arthritis 08/2004
1	Wounds and Injuries (Trauma) 07/2004
1	Fever (Fevers) 01/2004
1	Exanthema (Rash) 01/2004
1	Drug Hypersensitivity Syndrome 01/2004
1	Vulvar Lichen Sclerosus 07/2003

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 01/2019 - 12/2006
5	ProteomeIBA 01/2019 - 05/2009
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2009 - 12/2003
4	HhAntag691IBA 12/2018 - 06/2015
4	Pharmaceutical PreparationsIBA 06/2015 - 03/2003
2	Monoclonal AntibodiesIBA 08/2012 - 05/2009
2	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 08/2004 - 07/2004
1	Creatine Kinase (Creatine Phosphokinase)IBA 01/2017
1	sonidegibIBA 10/2016
1	VemurafenibIBA 03/2015
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 03/2015
1	Extracellular Matrix ProteinsIBA 03/2015
1	ResveratrolIBA 03/2015
1	Angiogenesis InhibitorsIBA 05/2014
1	DesminIBA 05/2014
1	ElementsIBA 03/2014
1	Cisplatin (Platino)FDA LinkGeneric 07/2013
1	Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)IBA 08/2012
1	VimentinIBA 08/2012
1	IpilimumabIBA 08/2012
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2012
1	Therapeutic UsesIBA 01/2012
1	ciglitazoneIBA 01/2012
1	Troglitazone (Rezulin)FDA Link 01/2012
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 01/2012
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2012
1	LigandsIBA 01/2012
1	15-deoxyprostaglandin J2IBA 01/2012
1	PaxillinIBA 01/2012
1	Irritants (Vesicants)IBA 01/2011
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 08/2010
1	TenascinIBA 08/2010
1	Endothelin-1 (Endothelin 1)IBA 08/2010
1	Indicators and Reagents (Reagents)IBA 08/2010
1	3,3',4,4',5,5'-hexahydroxystilbeneIBA 06/2010
1	StilbenesIBA 06/2010
1	Bevacizumab (Avastin)FDA Link 05/2009
1	matrigelIBA 05/2009
1	ErbB Receptors (EGF Receptor)IBA 05/2009
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 05/2009
1	CarcinogensIBA 05/2009
1	PeriostinIBA 05/2009
1	Biomarkers (Surrogate Marker)IBA 05/2009
1	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 12/2006
1	Messenger RNA (mRNA)IBA 12/2006
1	Dimethyl FumarateIBA 12/2006
1	Green Fluorescent ProteinsIBA 04/2005
1	Blocking AntibodiesIBA 08/2004
1	Biological ProductsIBA 08/2004
1	IntegrinsIBA 07/2004
1	monocrystalline iron oxide nanoparticle (MION)IBA 07/2004
1	Surface Antigens (Surface Antigen)IBA 07/2004
1	Carbamazepine (Tegretol)FDA LinkGeneric 01/2004
1	Tacrolimus (Prograf)FDA LinkGeneric 07/2003
1	Paclitaxel (Taxol)FDA LinkGeneric 03/2003
1	Liposomes (Liposome)IBA 03/2003
1	cremophor ELIBA 03/2003

Therapy/Procedure

3	Therapeutics 01/2018 - 08/2010
1	Extracorporeal Shockwave Therapy 01/2018
1	Immunotherapy 01/2016
1	Drug Therapy (Chemotherapy) 01/2013
1	Heterologous Transplantation (Xenotransplantation) 05/2009
1	Intraperitoneal Injections 12/2003